Voltage-gated Ca 2ϩ channels of chromaffin cells are modulated by locally released neurotransmitters through autoreceptor-activated G-proteins. Clear evidence exists in favor of a Ca 2ϩ channel gating inhibition mediated by purinergic, opioidergic, and ␣-adrenergic autoreceptors. Few and contradictory data suggest also a role of ␤-adrenergic autoreceptors (␤-ARs), the action of which, however, remains obscure. Here, using patch-perforated recordings, we show that rat chromaffin cells respond to the ␤-AR agonist isoprenaline (ISO) by either upmodulating or downmodulating the amplitude of Ca 2ϩ currents through two distinct modulatory pathways. ISO (1 M) could cause either fast inhibition (ϳ25%) or slow potentiation (ϳ25%), or a combination of the two actions. Both effects were completely prevented by propranolol. Slow potentiation was more evident in cells pretreated with pertussis toxin (PTX) or when ␤ 1 -ARs were selectively stimulated with ISO ϩ ICI118,551. Potentiation was absent when the ␤ 2 -AR-selective agonist zinterol (1 M), the protein kinase A (PKA) inhibitor H89, or nifedipine was applied, suggesting that potentiation is associated with a PKA-mediated phosphorylation of L-channels (ϳ40% L-current increase) through ␤ 1 -ARs. The ISO-induced inhibition was fast and reversible, preserved in cell treated with H89, and mimicked by zinterol. The action of zinterol was mostly on L-channels (38% inhibition). Zinterol action preserved the channel activation kinetics, the voltage-dependence of the I-V characteristic, and was removed by PTX, suggesting that ␤ 2 AR-mediated channel inhibition was mainly voltage independent and coupled to G i /G o -proteins. Sequential application of zinterol and ISO mimicked the dual action (inhibition/potentiation) of ISO alone. The two kinetically and pharmacologically distinct ␤-ARs signaling uncover alternative pathways, which may serve the autocrine control of Ca 2ϩ -dependent exocytosis and other related functions of rat chromaffin cells.
Introduction
Voltage-gated Ca 2ϩ channels are crucial for Ca 2ϩ signaling during secretion. In adrenal chromaffin cells, released neurotransmitters act autocrinally on Ca 2ϩ channel gating (Albillos et al., 1996a; Currie and Fox, 1996) and the associated Ca 2ϩ -dependent secretion (Lim et al., 1997; Powell et al., 2000; Ulate et al., 2000) . N-and P/Q-channels are inhibited by G-protein-coupled receptors (GPCRs) (Kleppisch et al., 1992; Gandía et al., 1993; Albillos et al., 1996b ) by a mechanism resolved in membrane micropatches, suggesting close localization of Ca 2ϩ channels, GPCRs, and secretory events (Carabelli et al., 1998) . Also Ca v 1 L-channels can be downregulated through membrane-delimited interactions with GPCRs (Hernández-Guijo et al., 1999; Carabelli et al., 2001) or by cGMP/protein kinase G-mediated pathways (Carabelli et al., 2002) . Conversely, L-channels are upregulated by cAMP elevations or by D1-and ␤-adrenergic autoreceptor (AR) stimulation (Artalejo et al., 1990; Doupnik and Pun, 1992; Carabelli et al., 2001; Carbone et al., 2001 ), thus furnishing a wide range of autocrine Ca 2ϩ -current control. The most intriguing issue regarding the GPCRs modulating L-channel gating concerns the existence of a ␤-AR-mediated modulation, which can inhibit (Hernández-Guijo et al., 1999) or potentiate ) L-channel activity of rat chromaffin cells (RCCs). This peculiarity is of relevance because adrenaline (A) and noradrenaline (NA) are stored in chromaffin granules and released at concentrations of 0.5-1 M (Jankowski et al., 1993) , and ␤-AR stimulation increases the basal release of catecholamines in bovine chromaffin cells (BCCs) (Parramon et al., 1995) . The existence of two distinct ␤-AR-mediated responses may derive from the activation of two different signaling cascades.
(1) ␤ 1 -ARs act exclusively via G s -proteins coupled to adenylyl cyclase (AC), cAMP production, protein kinase A (PKA) activation, and increased L-channel activity (Bean et al., 1984) ; (2) ␤ 2 -ARs couple to both G s -and G i -proteins and give rise to various specific ␤-AR-mediated pathways (Xiao et al., 1995; Daaka et al., 1997; Kilts et al., 2000) . In rodent cardiac cells, ␤ 2 -ARs are preferentially localized to caveole and coupled to PTX-sensitive G i -proteins, thus confining cAMP signaling to compartmentalized regions (Xiao et al., 1995 . A localized action after ␤ 2 -AR stimulation has been reported recently in hippocampus, ensuring highly localized and rapid cell signaling (Davare et al., 2001 ). Thus, ␤ 2 -ARs activate membranedelimited pathways in clear contrast to the remote ␤ 1 -AR stimulation, which is diffusive and involves distal effectors.
Here, using recording conditions close to physiological (10 mM Ca 2ϩ and perforated-patch recordings in place of Ba 2ϩ and whole-cell recording conditions), we show that RCCs possess two distinct ␤ 1 -and ␤ 2 -AR signaling pathways. The ␤ 1 -AR cascade acts by selectively upregulating the L-channel through a PKAmediated pathway and develops slowly according to its diffusive characteristics. On the contrary, the ␤ 2 -AR signaling is fast and primarily coupled to PTX-sensitive G-proteins. It produces marked depression on the L-channel (ϳ40%), which represents the dominant Ca 2ϩ channel subtype in RCCs. The two ␤-ARs act in parallel, giving rise to considerable Ca 2ϩ current modifications, which may be relevant both for the control of catecholamine secretion and for the opposing effects that the two receptors exert on cell apoptosis (Communal et al., 1999; Zaugg et al., 2000) .
Materials and Methods
Isolation and culture of rat adrenal medulla chromaffin cells. All experiments were performed in accordance with the guidelines established by the National Council on Animal Care and were approved by the local Animal Care Committee of Turin University. Chromaffin cells were obtained from adult female Sprague Dawley rats (200 -300 gm), which were killed by cervical dislocation. Cell isolation and plating were achieved as described previously (Hernández-Guijo et al., 1999) . Briefly, after removal, the adrenal glands were placed in Ca 2ϩ -and Mg 2ϩ -free Locke's buffer containing (in mM): 154 NaCl, 3.6 KCl, 5.6 NaHCO 3 , 5.6 glucose, and 10 HEPES, pH 7.2, at room temperature. The glands were decapsulated, and the medullas were precisely separated from the cortical tissue. Medulla digestion was achieved for 30 min at 37°C in Ca 2ϩ -and Mg 2ϩ -free Locke's buffer containing 1.5 mg/ml collagenase, 3 mg/ml bovine serum albumin. Gentle agitation every 10 min with a Pasteur pipette facilitated cell separation. The cell suspension was then centrifuged for 10 min at 120 ϫ g, washed two times, and resuspended in 1 ml DMEM. Cells were plated in four-well plastic dishes treated with poly-L-ornithine (1 mg/ml) and laminin (5 g/ml in L-15 carbonate) by placing a drop of concentrated cell suspension in the center of each well. After 1 hr, 1 ml of DMEM supplemented with 5% fetal calf serum (Invitrogen, Grand Island, NY), 50 IU/ml penicillin, and 50 g/ml streptomycin (Invitrogen) was added to the wells. Cells were then incubated at 37°C in a watersaturated atmosphere with 5% CO 2 and used within 2-6 d after plating.
Current recordings, solutions, and data analysis. Ca 2ϩ currents were recorded by the perforated-patch whole-cell recording technique (Korn et al., 1991) using patch pipettes of thin borosilicate glass (Kimax 51; Witz Scientific, Holland, OH). For stimulation and acquisition we used an EPC-9 amplifier and PULSE software (HEKA-Elektronik, Lambrecht, Germany).
The perforated patch was obtained using pipettes containing 50 -100 g/ml amphotericin B (Sigma, St. Louis, MO) and a pipette-filling solution containing (in mM): 135 CsMeSO 3 , 8 NaCl, 2 MgCl 2 , 20 HEPES, pH 7.3 with CsOH. The external bath contained (in mM): 135 NaCl, 2.8 KCl, 10 CaCl 2 , 2 MgCl 2 , 20 glucose, 10 HEPES, pH 7.4 with NaOH. Amphotericin B was dissolved in dimethyl sulfoxide (DMSO) and stored at Ϫ20°C in stock aliquots of 50 mg/ml. Fresh pipette solution was prepared every 2 hr. To facilitate the sealing, the pipette was first dipped in a beaker containing the internal solution and then back-filled with the same solution containing amphotericin B. Pipettes with series resistance of 2-3 M⍀ were used to form gigaseals. Recording of Ca 2ϩ currents started when the access resistance decreased below 15 M⍀, which usually happened within 10 min after sealing (Rae et al., 1991) . Series resistance was compensated by 80% and monitored throughout the experiment. Because the drugs that were applied to the external solution did not affect the liquid junction potential (LJP), the indicated voltages were not corrected for the LJP at the interface between the pipette solution (135 CsMeSO 3 ) and the bath (135 NaCl), which was Ϫ13 mV (Barry and Lynch, 1991) . The estimated Donnan equilibrium potential between the cell interior and the pipette was below Ϫ2 mV. Thus, the voltage bias for the present measurements was between Ϫ13 and Ϫ15 mV. Indeed, when comparing the present measurements with previous recordings on whole-cell clamped RCCs, in which LJPs were not compensated, the voltage bias was approximately Ϫ10 mV (Gandía et al., 1995; Hernández-Guijo et al., 1999) (see Results) . Ca 2ϩ currents were evoked by step depolarizations of 25-50 msec to a fixed potential (ϩ10 mV) or by ramp commands from Ϫ40 to ϩ70 mV with a slope of 2.2 V/sec. The holding potential was Ϫ40 mV throughout the experiments, which should correspond to approximately Ϫ63 mV when compared with Ca 2ϩ currents measured in 5 mM Ba 2ϩ and wholecell recordings (see Results). Fast capacitative transients during step depolarizations were minimized on-line by the patch-clamp analog compensation. Uncompensated capacitative currents were further reduced by subtracting the averaged currents in response to P/4 hyperpolarizing pulses. All of the experiments were performed at room temperature (22-24°C). Data are given as mean Ϯ SEM for n ϭ number of cells. Statistical significance was calculated using Student's paired t test, and p Ͻ 0.05 was considered significant.
External solutions were exchanged using a gravity system consisting of a multibarreled pipette with a single outlet and five inlets controlled by solenoid electrovalves (The Lee Company, Westbrook, CO). The tip of the perfusion pipette (40 -50 m) was placed ϳ40 m from the cell. In this way the perfusion solution could be changed within 50 msec (Pollo et al., 1993) . Nifedipine, isoprenaline, propranolol, ICI 118,551, and H7 were purchased from Sigma. H89 was obtained from CN Biosciences Inc. (Darmstadt, Germany). Zinterol (kindly provided by Bristol-Meyers Squibb, Wallingford, CT) was prepared as a 1 mM stock solution in DMSO and dissolved to a final concentration (0.3-10 M) just before the experiments. Protein kinase inhibitors (H89 and H7) were dissolved in distilled water and kept frozen in aliquots. Toxins -conotoxin (CTx)-GVIA, -agatoxin (Aga)-IVA, and -conotoxin (CTx)-MVIIC were purchased from Peptide Institute (Osaka, Japan) and prepared to the final concentration as described previously (Magnelli et al., 1998) .
Results

Ca
2؉ currents in perforated-patch conditions In 10 mM Ca 2ϩ and perforated-patch conditions, the voltagegated Ca 2ϩ currents of RCCs were stable and could be recorded for long periods of time (15-20 min) without significant rundown (Fig. 1 A) . During brief depolarizations (50 msec), Ca 2ϩ currents activated at approximately Ϫ30 mV, reached maximal amplitude at approximately ϩ10 mV, and decreased at higher potentials ( Fig. 1 B, F) . Compared with previous measurements in 5 mM Ba 2ϩ and whole-cell recording conditions (Hernández-Guijo et al., 1999) , the I-V characteristics in 10 mM Ca 2ϩ and perforated-patch conditions peaked 23 mV toward more positive voltages (Fig. 1C, F) . This was caused by the sum of the uncompensated liquid junction potential between pipette and bath solution (approximately ϩ10 mV; see Materials and Methods) and the voltage shift associated with the more effective screening of Ca 2ϩ with respect to Ba 2ϩ on membrane negative surface charges (approximately ϩ13 mV).
RCCs express a large percentage (40 -50%) of L-type currents (Gandía et al., 1995; Hollins and Ikeda, 1996) . This was evident from the block induced by adding 3 M nifedipine to the bath solution ( Fig. 1 B, C) . The dihydropyridine (DHP) blocked quickly and reversibly ϳ50% of the total currents, in good agreement with previous reports. Notice that in control conditions, the percentage of inactivation, estimated by measuring the ratio between peak and steady-state current at the end of the pulse of 50 msec, changed greatly from cell to cell: from a minimum of 15% to a maximum of 55%. As shown below, this variability did not influence the quantification of ISO action on Ca 2ϩ currents.
The dual action of isoprenaline on Ca 2؉ currents Addition of 1 M ISO to the bath caused a potentiation of the total current in 40 of 215 tested cells (18.6%) (Fig. 2 A, E) , an inhibition in 72 cells (33.5%) (Fig. 2 B, E) , a combination of the two actions in 66 cells (30.7%) (Fig. 2C,E) , or no effects at all in 37 cells (17.2%) (Fig. 2 D, E) . The onset of potentiation required ϳ4 min to be complete, whereas the offset was significantly faster (ϳ1 min). After a lag of 20 -30 sec the current raised slowly and mono-exponentially with a mean on of 90.3 sec (n ϭ 8) (Fig.  3A 1 ), whereas the offset started with no delay and developed approximately fivefold faster (mean off ϭ 21.6 sec). The onset of inhibition was significantly faster than potentiation. In most cases the inhibition was complete in Ͻ1 min, and washout required a comparable time. A fit with an exponential function for the onset and offset of the inhibition gave average time constants of 8.3 sec ( on ) and 12.6 sec ( off ), respectively (n ϭ 10) (Fig. 3B 1 ) . When the two effects occurred on the same cell, the fast inhibition always anticipated the slower setting of potentiation. On average, the current amplitude first decreased by 26.3 Ϯ 1.3% (n ϭ 35) and then increased by 26.0 Ϯ 1.7% (n ϭ 35) to reach the original control levels or, in some case, even higher values (Fig.  2C ). On the other hand, potentiation and inhibition were comparable when they occurred in isolation (25.2 Ϯ 1.9 vs 24.1 Ϯ 1.2%) (Fig. 2 F) , suggesting that potentiation did not overwhelm the ISO-induced inhibition and that the two modulations were more or less additive with a large degree of independence. The inhibition caused little or no changes to the I-V relationships (Fig. 3B 2 ), indicating no sign of voltage-dependent effects on voltage-gated Ca 2ϩ channels. The potentiation, on the contrary, shifted by ϳ7 mV to the left the potential of halfmaximal activation (Fig. 3A 2 , crosses) , very likely because of the selective potentiation of L-channels, which activate at more negative voltages compared with the other high-threshold Ca 2ϩ channels (Pollo et al., 1993) . Inhibition and potentiation also caused few or no changes to the activation-inactivation time course of Ca 2ϩ currents. In most cases, depressed or potentiated currents could nicely overlap by simple amplitude scaling, as illustrated in Fig. 3, A 3 and B 3 .
The results of Figures 2 and 3 are in qualitative agreement with recent findings in which mixtures of A and NA were found to produce a 34% inhibition of total Ba 2ϩ current in whole-cell clamped RCCs (Hernández-Guijo et al., 1999) . As reported, the combined action of NA and A caused almost no changes to the activation kinetics and was insignificantly voltage dependent compared with the pronounced voltage-dependent inhibition by ATP and opioids. The action of the catecholamines was larger than that reported here (25%). This could be attributed to various causes. First, in whole-cell clamp recordings, the action of NA ϩ A was mediated by ␣-and ␤-ARs, whereas in the case of Figure 2 the action is limited to ␤-ARs. Stimulation of ␣-ARs produces a sizeable reduction of Ca 2ϩ currents in bovine chromaffin cells (Kleppisch et al., 1992) . Second, the A-and NA-induced inhibition is mediated by G i /G o -proteins (Albillos et al., 1996a) ; it is thus probable that whole-cell recordings made in the presence of high concentrations of GTP (300 M) enhance the inhibitory effects of the neurotransmitters with respect to the perforated-patch conditions, in which the basal levels of GTP may be significantly lower. A final consideration concerns the existence of the ISO-induced potentiation, which was overlooked in whole-cell recording conditions in either RCCs (Hernández-Guijo et al., 1999) or BCCs (Albillos et al., 1996a) . This modulation is usually associated with the presence of PKA catalytic subunits responsible for L-channel phosphorylation, which may be lost during cell dialysis but preserved in cell-attached or perforated-patch conditions (Fig. 2) .
The dual action of isoprenaline is mediated by ␤-ARs
The dual action of ISO was fully prevented by propranolol (1 M). The unspecific ␤-AR inhibitor blocked both the ISOinduced inhibition and potentiation. Figure 4 shows two examples of the antagonistic action of propranolol pooled from 11 cells in which the two effects were observed either in isolation or superimposed. In one case, ISO alone caused only a marked potentiation (Fig. 4 A) . In the other case, ISO produced an inhibition followed by a potentiation (Fig. 4 B) . The dual action of ISO was also fully antagonized by adding mixtures of the ␤ 1 -and ␤ 2 -selective receptor antagonists CGP 20712A (0.3 M) and ICI 118,551 (0.1 M) (n ϭ 4; data not shown), indicating that both potentiation and inhibition were mediated by ␤-ARs.
Potentiation acts on L-channels whereas inhibition affects Land non-L-channels
The presence of a Ca 2ϩ current potentiation induced by ISO is indicative of the presence of a ␤-AR modulation on L-type channels mediated by cAMP/PKA. To verify this, we first tested whether the Ca 2ϩ current potentiation observed in ϳ50% of the cells persisted in the presence of nifedipine or after application of a PKA inhibitor, such as H89 and H7. As shown in Figure 5A , the DHP nifedipine (3 M) completely prevented the slow potentiating effects of ISO observed before application of the L-channel blocker (n ϭ 5). The action of the ␤-AR agonist on nifedipineresistant currents was exclusively inhibitory. In 17 cells pretreated with nifedipine, the ISO-induced inhibition was 12.3 Ϯ 2.2% after 1 min and 13.1 Ϯ 1.9% after 5 min of the agonist application, suggesting that as for other autoreceptor-mediated pathways (Gandía et al., 1993; Albillos et al., 1996b) , the non-L-type channels of RCCs (N, P/Q, R) are negatively coupled to ␤-ARs.
Acute application of H89 (5 M; n ϭ 12) or 30 min pretreatment with H7 (200 M; n ϭ 7) always prevented the potentiating action of ISO. Figure 5 , B and C, shows the action of the PKA inhibitor in two representative cases. In the first case (Fig. 5B) , ISO had an inhibitory effect. H89 did not cause any significant decrease, and reapplication of ISO induced a comparable inhibition. In the second case (Fig. 5C ), ISO induced a Ca 2ϩ current potentiation, whereas H89 caused a partial decrease of control currents, which required several minutes to settle, suggesting the existence of a robust percentage of PKA-phosphorylated Ca 2ϩ channels under basal conditions. Subsequent applications of ISO had no effect. These data suggest that potentiation proceeds through a cAMP/PKA pathway and is limited to L-channels (Fig. 5A) , whereas the inhibition proceeds regardless of the availability of PKA.
The ability of H89 and H7 to completely abolish the potentiating effect allowed a better quantification of the inhibitory effects of ISO on L-and non-L-channels. In seven cells pretreated with H7, we tested the effects of ISO before and after nifedipine application (Fig. 6 A) and observed no sign of potentiation. Although the two Ca 2ϩ channel families contributed almost equally to the total current (52.4 Ϯ 1.9% L and 46.9 Ϯ 1.5% non-L), the former were more inhibited than the latter: 33.2 Ϯ 5.8% (Fig. 6 B, black bars) and 10.5 Ϯ 4.5% ( gray bars), respectively. Onset of inhibition was fast for both families of Ca 2ϩ channels, and the same was true for the offset.
PTX prevents Ca
2؉ channel inhibition favoring the potentiation through ␤ 1 -ARs An increasing number of reports on cardiac and neuronal L-type channels of rodent support the view of an effective coupling between ␤ 2 -ARs and PTX-sensitive G i /G o -proteins Davare et al., 2001) . PTX treatment of rat heart cells was shown to potentiate the responses to ISO, very likely because of the removal of a negative coupling mediated by G i /G o -proteins on L-channels (Xiao et al., 1995 Zhang et al., 2000) . In chromaffin cells, PTX-sensitive G-proteins are negatively cou- pled to L-and non-L-type channels (Gandía et al., 1993; Albillos et al., 1996a,b; Currie and Fox, 1996; Carabelli et al., 1998; Hernández-Guijo et al., 1999 ); thus we hypothesized that the inhibitory effects induced by ISO might have been related to an effective coupling between ␤ 2 -ARs and G i /G o -proteins to downregulate Ca 2ϩ channel gating, whereas ␤ 1 -ARs might have been responsible for the opposite potentiating action mediated by cAMP/PKA. If this were the case, cell pretreatment with PTX would be expected to remove the inhibition and uncover the potentiating action of ISO through ␤ 1 -ARs. Indeed, in 60% of cells treated for 12 hr with 100 ng/ml PTX (9 of 15 cells), we observed increases in current amplitude similar to control cells (25.9 Ϯ 1.6% with PTX vs 25.2 Ϯ 1.9% in control) (Fig. 7A ) but a higher probability of success with respect to the potentiation of control cells (60 vs 18.6%). In the remaining six cells, ISO had no effect. Thus, PTX treatment was sufficient to abolish the inhibitory action of ISO, suggesting that as for other neurotransmitters (ATP and opioids), G i /G o -proteins mediated the inhibition of Ca 2ϩ channels by ␤-ARs.
Further support for the hypothesis that inhibition is mediated by ␤ 2 -AR and potentiation is controlled by ␤ 1 -AR stimulation came by testing the effects of ISO (1 M) on the presence of the specific ␤ 2 -AR antagonist ICI 118,551 (0.1 M) (␤ 1 -AR stimulation). In 10 cells perfused with ISO ϩ ICI 118,551, we never observed inhibitory effects. ␤ 1 -AR stimulation caused a clear potentiation in eight cells (21.3 Ϯ 1.8%) (Fig. 7B) , whereas it had no action in the remaining two (data not shown).
Ca
2؉ channel inhibition is mediated by ␤ 2 -ARs Zinterol is an agonist with a 25-fold higher affinity for ␤ 2 -ARs over ␤ 1 -ARs and is often used as a selective ␤ 2 -AR agonist, in the range between 0.1 and 1 M (Minneman et al., 1979) . We therefore tested whether zinterol was able to mimic the inhibitory effects of ISO, which we expected to be selectively mediated by ␤ 2 -AR. In agreement with this hypothesis, we found that in all the cells tested (n ϭ 56), short (40 sec) or long (5 min) applications of 1 M zinterol produced no sign of Ca 2ϩ current potentiation (Fig. 8 A, B) . In 75% of the cells, zinterol (1 M) caused an average inhibition of 21.7 Ϯ 1.0% (n ϭ 42), which was comparable with that induced by ISO alone (mean 24.1%; p Ͼ 0.05), whereas in the remaining 25% of cells zinterol had no effect. The action of zinterol was fast and reversible. The onset was comparable with that of ISO (mean on 6.5 sec; n ϭ 10) (Fig. 8C) , whereas washout was particularly fast (mean off 6.6 sec; n ϭ 7) when the agonist was applied for short periods of 40 sec (Fig. 8C, solid line) but became sixfold slower (mean off ϭ 38.1 sec, n ϭ 7) when applied for longer periods of 5 min (Fig. 8C, dashed line) . A slow off for zinterol with respect to ISO is consistent with a high affinity of the agonist for ␤ 2 -ARs and is in agreement with previous observations of ␤ 2 -AR stimulation in frog myocytes in which the washout of zinterol was particularly slow (Skeberdis et al., 1997) . The inhibitory action was mainly independent of voltage as shown by the down-scaling on Ca 2ϩ currents, which occurred with nearly no changes on the activation kinetics (Fig. 8 B) , and by the unaltered shape and voltage of half-maximal activation of the I-V characteristics (Fig. 8 D) . Increasing concentrations of zinterol from 0.3 to 10 M caused the same degree of block (21-23%) (Fig. 8 E) . The inhibition decreased to 9.2 Ϯ 1.7% at 0.1 M (n ϭ 4) and to even lower values (not clearly measurable) at lower concentrations. All this suggests that 1 M is a saturating concentration for maximal activation of ␤ 2 -ARs in RCCs.
Consistent with the idea that the inhibitory effects of zinterol were mediated by ␤ 2 -ARs coupled to PTX-sensitive G i /G oproteins, the action of the agonist was fully prevented by application of 0.1 M ICI 118,551 or cell treatment with PTX (Fig. 9) . In all the cells in which 1 M zinterol produced a sizeable inhibition (22.8 Ϯ 1.5%; n ϭ 15), the ␤ 2 -AR antagonist abolished the action of the agonist and caused no detectable changes on Ca 2ϩ currents (Fig. 9A) . In PTX-treated cells (n ϭ 8), even long exposures to zinterol had no effect (Fig. 9B) . There was neither inhibition nor potentiation, suggesting that ␤ 2 -AR stimulation in RCCs is strictly coupled to G i /G o -proteins, and at variance with other cell preparations (Xiao et al., 1995; Skeberdis et al., 1997; Zhang et al., 2000; Davare et al., 2001 ), zinterol does not induce any measurable Ca 2ϩ current potentiation. Consistent with this, the action of zinterol was not affected by cell pretreatment with H89 (Fig.  9C, left) . Short-term (30 sec) and long-term (5 min) applications of the ␤ 2 -AR agonist in H89-pretreated cells produced inhibitions comparable to those of control cells (21.3 Ϯ 1.7% after 30 sec and 24.2 Ϯ 1.7% after 5 min) (Fig. 9C) .
As for ISO, nifedipine blocked a significant fraction of zinterol action (Fig. 10 A) , suggesting that the ␤ 2 -AR-mediated action was larger on L-than on non-L-channels. The mean depression of total currents was 22.7%, whereas that of L-and non-L-currents was comparable with the values given in Figure 6 B (33.4 and 12.2%, respectively) (Fig. 10 B) . To better evaluate the inhibitory effects of zinterol on L-channels, we tested the action of the agonists on RCCs in which N-and P/Q-currents were minimized by applying mixtures of -CTx-GVIA (1 M), -Aga-IVA (200 nM), and -CTx-MVIIC (2 M). Figure 10C shows that zinterol produces more or less the same degree of inhibition before and after -toxin treatment, implying a marked action on -toxinresistant currents. In 12 cells, zinterol blocked by 23.2 Ϯ 1.6% the control currents and by 43.9 Ϯ 2.3% the toxin-resistant ones (Fig.  10C, inset) . Given that -toxin-resistant currents in RCCs are mainly carried by L-channels and that R-currents stay in a ratio of 1:5 with respect to L-types, the true inhibition of L-currents is likely to be ϳ38%, i.e., comparable with that induced by ISO in H7-treated cells (33.2%) (Fig. 6 A) and slightly smaller than that induced by NA and A in whole-cell-clamped RCCs (48%) (Hernández-Guijo et al., 1999) .
A common pool of G i /G o -coupled receptors mediates the ␤ 2 -AR-induced inhibition
In a previous study on RCCs it was shown that separate or simultaneous activation of purinergic, opiodergic, and adrenergic autoreceptors (including ␤-ARs) produce the same degree of inhibition on L-currents by acting on a common pool of G i /G oproteins (Hernández-Guijo et al., 1999) . This suggests that the ␤ 2 -AR-mediated inhibition described here may be prevented if mixtures of opioids and ATP, capable of inhibiting the L-currents, already activate the same pool of G i /G o -proteins. The same cannot be concluded, however, for the potentiating effects mediated by ␤ 1 -ARs, which may still be able to potentiate the currents in the presence of opioids and ATP. Figure 11 A shows that the action of ISO on Ca 2ϩ currents, inhibited previously by maximum. The solid curves are the result of a fit with single exponential functions with time constants on ϭ 6.5 sec (n ϭ 10) and off ϭ 6.6 sec (after 40 sec; n ϭ 7) and off ϭ 38.1 sec (after 5 min; n ϭ 7). off values were calculated from cells on which zinterol was sequentially applied for short and long periods. D, I-V curves recorded before and during application of zinterol (1 M). Voltages of half-maximal activation indicated by the crosses (V 1/2 ) were Ϫ7.4 mV (control ) and Ϫ5.3 mV (zinterol ). E, Percentage of inhibition at different zinterol concentrations, showing that above 300 nM the percentage of inhibition is saturating. , is only stimulatory. Addition of ISO, after the fast inhibition induced by ATP and opioids, does not produce any further depression, but only a slow potentiating effect, which brings the current amplitude slightly above the control level with an onset comparable with that described previously (mean on 59.8 sec). In 20 similarly treated cells, we observed current increases similar to that of Figure 11 A. In 11 cells the potentiation was able to fully compensate for the inhibition, whereas in 9 cases there was no action. The same occurred if ISO followed the application of zinterol (Fig. 11 B) , mimicking the dual action illustrated in Figures 2C and 4 B. In nine cells, zinterol always produced inhibition of Ca 2ϩ currents, whereas subsequent application of ISO caused either a potentiation (six cells) or no effects (three cells). On average, the size of ISOinduced potentiation after zinterol exposure was comparable with the inhibition induced by zinterol, but in some case was even larger, as shown in Figure 11 B. In conclusion, the action of ISO on the Ca 2ϩ currents of RCCs appears to be composed of two components: (1) an inhibitory pathway mediated by ␤ 2 -ARs that shares the same pool of G i /G o -proteins of purinergic and opioidergic autoreceptors and (2) a stimulatory pathway mediated by ␤ 1 -ARs that acts regardless of the G i /G o -induced inhibition. A, The cell was tested for the effect of zinterol (1 M) before and during exposure to the ␤ 2 -AR-selective antagonist ICI 118,551. The antagonists could prevent the zinterol-induced inhibition. B, The PTX-treated cell was superfused with control external solution and tested for the action of zinterol (1 M) during the period indicated. In eight cells pretreated with PTX, zinterol had practically no action. C, The cell was initially superfused with a solution containing H89 (5 M) and then exposed to zinterol (1 M) for the periods indicated. H89 was unable to prevent the inhibitory effects of zinterol. Symbols, lettering, and traces have the same meaning as that in previous figures. 
Discussion
We have provided evidence that RCCs possess two ␤-adrenergic signaling pathways exerting opposite effects on L-type channels. The two mechanisms involve distinct ␤-ARs and second messenger cascades. In one case, the action is mediated by ␤ 1 -ARs and induces potentiation of L-channel activity through the activation of a cAMP/PKA pathway. In the second case, the action is mediated by ␤ 2 -ARs and produces fast inhibition of L-and non-Lcurrents. The two modulations occur either sequentially or in isolation, thus furnishing a wide range of Ca 2ϩ current amplitude variability, depending on the cell. Because adrenaline and noradrenaline are stored and released at high concentrations (Winkler and Westhead, 1980) and L-channels critically control the Ca 2ϩ -dependent exocytosis in rat adrenal glands (Nagayama et al., 1999) , the present modulations may be crucial for the autocrine control of catecholamine release from adrenal medullas.
The two modulations support the existence of an effective ␤-AR signaling cascade in RCCs and help to solve the apparent contradiction that L-channels of chromaffin cells may be either inhibited by G-proteins or potentiated by cAMP . In whole-cell recordings of RCCs, ␤-AR activation by released catecholamines produces marked L-channel inhibition (Hernández-Guijo et al., 1999) , whereas in cell-attached patches in which the catalytic subunits of the cAMP/PKA cascade are preserved, stimulation by ISO produces L-channel upregulation ). These observations find now a rationale in the coexistence of the two opposite signaling cascades, which appear voltage insensitive, i.e., down-modulation by G-proteins and upregulation by PKA do not require any special voltage sensitivity to occur.
The ␤ 1 -AR-mediated potentiation An interesting issue of this work is the uncovered ␤ 1 -AR stimulation in endocrine cells, which increases L-currents through a PKA-mediated pathway. This modulation was overlooked in previous works (Doupnik and Pun, 1994; Albillos et al., 1996b; Hollins and Ikeda, 1996; Hernández-Guijo et al., 1999) , for two reasons. First, the L-current increment in RCCs is modest (25% of I Ca , corresponding to 35-40% of L-currents) with respect to the sixfold increase in ventricular myocytes (Hartzell, 1988) . Second, there may be a loss of catalytic subunits responsible for PKAmediated channel phosphorylation during cell dialysis in wholecell recordings, which is preserved in patch-perforated (Figs. 2,  11 ) or cell-attached configuration ). The ␤ 1 -AR stimulation of L-channels in RCCs possesses most of the prerequisites of ␤ 1 -AR modulation in ventricular myocytes. The action is selective for L-channels and develops slowly. It is prevented by PKA inhibitors and persists after PTX treatment. At variance with cardiac myocytes, the amount of Ca 2ϩ current increase is significantly lower and recovers more quickly. This behavior may depend on (1) different ␤ 1 -AR and adenylate cyclase isoforms and level of expression, (2) density and localization of PKAs, phosphodiesterases, and phosphatases near active sites, and (3) compartmentation and coupling among ␤ 1 -ARs, signaling molecules, and downstream effectors.
Another interesting issue of ␤-AR stimulation in RCCs concerns the presence in some cases of basal levels of active PKA that is evident when RCCs are exposed to PKA inhibitors. This was not observed in BCCs ) and may be responsible for the larger size of L-currents in RCCs (Gandía et al., 1995) . The presence of a sustained basal level of active PKA may also be responsible for a PKA-mediated ␤ 1 -AR phosphorylation with consequent desensitization (Collins et al., 1992) , which could partially explain the smaller ISO-induced potentiation with respect to cardiac cells.
Various reports indicate a role for ␤ 1 -ARs in catecholamine secretion in BCCs (Greenberg and Zinder, 1982; Wann et al., 1988; Ligier et al., 1994) , but data concerning a modulatory action of ␤ 1 -ARs on L-channels are lacking. The most convincing evidence of ␤ 1 -AR modulation of L-channels in BCCs is indirect and shows that either ISO stimulation or forskolin stimulation induces cAMP increases and enhanced basal secretion of catecholamines (Parramon et al., 1995) . Our findings thus represent the first direct evidence of a ␤ 1 -AR-mediated potentiation of voltage-gated L-channels through a PKA signaling cascade in RCCs. This is of importance because cAMP production stimulates basal and evoked adrenal secretion (Morita et al., 1987; Przywara et al., 1996) , increases the quantal size of exocytotic events (Machado et al., 2001) , and upregulates T-type Ca 2ϩ channels and TTX-resistant Na ϩ channels in chronically exposed RCCs (Novara et al., 2002) .
Our data exclude a functional role for ␤ 3 -AR in RCCs. Block of ISO stimulation by propranolol or mixtures of ICI 118,551 and Figure 11 . ISO produces only potentiation after the inhibitory effects induced by purinergic, opioidergic, and ␤ 2 -adrenergic receptors. A, The cell was initially superfused with control external solution and then exposed to ATP (100 M), DPDPE (1 M), and DAMGO (10 M), which caused inhibition. Addition of ISO (1 M) caused no further depression but only a slow current potentiation. B, Sequential application of zinterol (1 M) and ISO (1 M) mimics the dual action of ISO shown in Figures 2C and 4 B, proving that inhibition is mediated by ␤ 2 -ARs, whereas potentiation by ISO proceeds through ␤ 1 -ARs. Symbols, lettering, and traces have the same meaning as in previous figures.
CGP 20712A indeed exclude the involvement of ␤ 3 -ARs in L-channel modulation (Strosberg, 1997) . Previous conclusions based on radioligand bindings about the presence of atypical ␤ 3 -ARs in BCCs appear doubtful. As suggested recently, commonly used iodinated ␤-AR ligands exhibit low potency for ␤ 3 -ARs and bind to ␤ 1 -ARs, ␤ 2 -ARs, and other receptors as well (Gauthier et al., 2000) .
The ␤ 2 -AR-mediated inhibition Our work produces the first evidence for a fast negative coupling between ␤ 2 -AR and voltage-gated L-channels through a common pool of G i /G o -proteins shared with purinergic and opioidergic autoreceptors (Hernández-Guijo et al., 1999) . Support for this comes from the following observations: (1) the inhibitory action of zinterol is fast ( on 6.5 sec at 1 M), (2) PTX fully prevents the effects of ␤ 2 -AR stimulation without uncovering any zinterolinduced potentiation of L-channel activity (Fig. 9B) , and (3) zinterol action is preserved by H89, thus excluding a possible role of PKA on L-current potentiation via ␤ 2 -ARs. From this point of view, the ␤ 2 -AR modulation of L-channels in RCCs is in line with a number of reports regarding adult rat ventricular myocytes in which ␤ 2 -ARs appear strongly coupled to G i -proteins and do not detectably elevate cytoplasmic cAMP levels (Kuznetsov et al., 1995; Laflamme and Becker, 1998) . In general, it is widely accepted that beside coupling to G s -proteins, ␤ 2 -ARs can couple to G i -proteins to (1) activate a phosphoprotein phosphatase 1 localized near cardiac L-channels (Xiao et al., 1995; Chen-Izu et al., 2000) , (2) lead signals to the nucleus through a Ras-MAP kinases pathway (Daaka et al., 1997) , (3) ensure rapid and specific activation of L-channels in hippocampus (Davare et al., 2001) , or (4) mediate anti-apoptotic nuclear signaling in adult cardiac myocytes (Communal et al., 1999; Chesley et al., 2000; Zhu et al., 2001 ).
In our case, the ␤ 2 -AR-mediated modulation is mainly inhibitory. We never observed Ca 2ϩ current potentiation with zinterol, even in the presence of PTX. This may be the consequence of subcellular compartmentation, already observed for neuronal and cardiac ␤ 2 -ARs, in which G-proteins, ACs, PKA-anchoringproteins, and phosphatases colocalize to form plasmalemma complexes, ensuring rapid activation or deactivation of specific signaling pathways Davare et al., 2001) . The possibility that the ␤ 2 -AR signaling switches from a G s -to a G imediated cascade after PKA-mediated phosphorylation of the receptor itself is unlikely (Daaka et al., 1997) . In fact, L-current inhibition by ISO or zinterol proceeds regardless of the presence of PKA inhibitors. Alternative possibilities are discussed by Steinberg and Brunton (2001) and include subcellular localization of phosphodiesterases in the vicinity of the receptor, maintaining low levels of cAMP independently of the degree of ␤ 2 -AR stimulation. Alternatively, it is possible that ␤ 2 -ARs are localized in membrane regions rich in G i -proteins and poor in G s -proteins (or ACs). Quick sequestration of ␤ 2 -ARs by G i -proteins may prevent G s -protein cascade, thus causing direct Ca 2ϩ current inhibition.
Relevance of L-channel modulation by ␤ 1 -and ␤ 2 -AR stimulation Ca 2ϩ currents in chromaffin cells are autocrinally modulated by two distinct inhibitory pathways: a voltage-dependent one acting on N-and P/Q-channels and a voltage-independent one acting on L-channels ). Both mechanisms are fast, membrane delimited, and G i /G o -protein mediated. The former is removed during strong or repeated depolarizations and may thus contribute to the rapid rise of intracellular Ca 2ϩ and catecholamine secretion during maximal sympathetic stimulation (fight or flight response). The latter may act as a constant negative feedback to limit the outcome of catecholamines during basal and sustained chromaffin cell activity. The slow ␤ 1 -AR L-channel potentiation described here appears suitable to remove the fast autocrine inhibition of L-channels induced by purinergic, opioidergic, and ␤ 2 -ARs and to further support Ca 2ϩ rising induced by the quick removal of non-L-type channel inhibition during repeated stimulation. However, the role of ␤ 1 -ARs may not be linked only to L-channel modulation. cAMP elevation has been shown to act downstream of the Ca 2ϩ -entry by enhancing the size of quantal events (Machado et al., 2001) , the depolarizationinduced exocytosis (V. Carabelli, A. R. Artalejo, E. Carbone, unpublished results), and the density of newly available T-type channels with consequent increased cell excitability (Novara et al., 2002) . The role of ␤ 2 -AR appears less evident but nevertheless interesting. The ␤ 2 -AR modulation described here resembles that induced by purinergic and opioidergic receptors and would probably ensure Ca 2ϩ channel inhibition in those cells in which either the content of ATP and opioids is particularly low or purinergic and opioid receptors are weakly expressed (Bunn et al., 1988) . However, the role of ␤ 2 -ARs may also be linked to crucial cell functions indirectly related to Ca 2ϩ channels, such as the anti-apoptotic action developed via G i -proteins to counterbalance the negative action of ␤ 1 -ARs on cell survival (Communal et al., 1999; Chesley et al., 2000) .
